MONDAY, July 1, 2024 -- A liberal transfusion strategy does not reduce the risk of unfavorable neurologic outcome at six months among critically ill...

MONDAY, June 17, 2024 -- For adolescents with severe obesity, meal replacement therapy (MRT) plus financial incentives (FIs) yield a greater...

MONDAY, June 24, 2024 -- For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a...

FRIDAY, June 28, 2024 -- An individualized, progressive walking and education intervention is beneficial for prevention of recurrence of low back...

June 24, 2024 -- The U.S. Food and Drug Administration (FDA) has approved PiaSky (crovalimab-akkz) for the treatment of adult and pediatric patients...

MONDAY, June 24, 2024 -- For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a...

A recent study conducted by the WifOR Institute has shed light on the significant benefits of early and intensified treatment strategies for Type 2...

THURSDAY, June 27, 2024 -- Immunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe...

TUESDAY, June 25, 2024 -- For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1...

TUESDAY, June 18, 2024 -- For children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is safe and effective,...